In last trading session, iBio Inc (NASDAQ:IBIO) saw 0.79 million shares changing hands with its beta currently measuring 1.08. Company’s recent per share price level of $3.22 trading at -$0.58 or -15.13% at ring of the bell on the day assigns it a market valuation of $31.84M. That closing price of IBIO’s stock is at a discount of -113.98% from its 52-week high price of $6.89 and is indicating a premium of 53.42% from its 52-week low price of $1.50. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.5 million shares which gives us an average trading volume of 513.79K if we extend that period to 3-months.
For iBio Inc (IBIO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.32 in the current quarter.
iBio Inc (NASDAQ:IBIO) trade information
Upright in the red during last session for losing -15.13%, in the last five days IBIO remained trading in the red while hitting it’s week-highest on Wednesday, 04/02/25 when the stock touched $3.22 price level, adding 23.88% to its value on the day. iBio Inc’s shares saw a change of 31.63% in year-to-date performance and have moved -21.72% in past 5-day. iBio Inc (NASDAQ:IBIO) showed a performance of -47.56% in past 30-days. Number of shares sold short was 0.85 million shares which calculate 0.9 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 3.6 to the stock, which implies a rise of 10.56% to its current value. Analysts have been projecting 3.6 as a low price target for the stock while placing it at a high target of 3.6. It follows that stock’s current price would drop -11.8% in reaching the projected high whereas dropping to the targeted low would mean a loss of -11.8% for stock’s current value.
iBio Inc (IBIO) estimates and forecasts
This year revenue growth is estimated to rise 77.78% from the last financial year’s standing.
2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 100k for the same. And 2 analysts are in estimates of company making revenue of 100k in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 57.55% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 60.55% while estimates for its earnings growth in next 5 years are of 45.01%.
iBio Inc (NASDAQ:IBIO)’s Major holders
Insiders are in possession of 7.21% of company’s total shares while institution are holding 26.65 percent of that, with stock having share float percentage of 28.72%. Investors also watch the number of corporate investors in a company very closely, which is 26.65% institutions for iBio Inc that are currently holding shares of the company.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 73.14 shares of worth $0.24 million or 0.74% of the total outstanding shares. The later fund manager was in possession of 45.79 shares on Feb 28, 2025 , making its stake of worth around $0.15 million in the company or a holder of 0.46% of company’s stock.
